A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Clinical trial NCT04174196 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04174196
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmacytoma Plasmacytoma of Bone Multiple Myeloma

Start date: 2019-11-19
Primary completion: 2026-11-19
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.